On November 19, the Engelberg Center for Health Care Reform at Brookings hosted an event examining the outlook and opportunities for biomedical innovation in a challenging fiscal environment. Leaders in the field offered their thoughts on future directions of and policy priorities for the innovation enterprise. Following a brief keynote, a panel of senior thought leaders provided further discussion on actionable next steps to improve biomedical innovation.
Download the executive summary » (PDF)
Download the panelist biographies » (PDF)
New Policy Directions for Biomedical Innovation
Agenda
-
November 19
-
Priorities for Biomedical Innovation in a Challenging Fiscal Environment
1:45 pm
Ed Penhoet Director - Alta Partners -
Finding the Path Forward for Biomedical Innovation
2:25 pm
Christopher Austin Director, National Center for Advancing Translational Sciences - National Institutes of HealthDeborah Brooks Co-Founder and Executive Vice Chairman - The Michael J. Fox FoundationRobert Conley Regulatory Leader and Distinguished Lilly Scholar - Eli Lilly and CompanyJohn Mendelsohn Professor, Department of Experimental Therapeutics, Division of Cancer Medicine and Director, Khalifa Institute for Personalized Cancer Therapy - The University of Texas MD Anderson Cancer CenterEarl Steinberg Executive Vice President of Innovation & Dissemination - Geisinger Health Solutions
-